GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN

/PRNewswire/ -- GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to prevent life-threatening pneumonia,...

Related Keywords

Adelaide ,South Australia ,Australia ,Australian ,Tim Hirst ,Paul Rolan ,Vaccines Ltd ,Australian Government Research ,Innovation Fund ,Chief Medical Officer ,Chief Executive Officer ,South Australian Government ,Gpn Vaccines ,